key: cord-0311420-12xazu67
authors: Garg, A.; Subramain, M.; Barlow, P. B.; Garvin, L.; Hoth, K. F.; Dukes, K.; Hoffman, R. M.; Comellas, A. P.
title: Patient experience with healthcare: Feedback for a Post COVID-19 clinic at a tertiary care center in rural area
date: 2021-11-21
journal: nan
DOI: 10.1101/2021.11.20.21266640
sha: 99563b83853c5a7142657fcb082cf605dca90c35
doc_id: 311420
cord_uid: 12xazu67

Purpose: Post-acute sequelae of SARS-CoV-2 infection(PASC) is a complex condition with multi-system involvement. We assessed patients perspectives and experience with a PASC clinic established at University of Iowa in June 2020. Methods: We conducted a mixed-method survey in June 2021 to ask PASC clinic patients about 1) PASC symptoms and their impact on physical and mental health, and cognition using the PROMIS Global Health and Cognitive Function abilities items, and 2) satisfaction with clinic services and referrals, barriers to care, and recommended support resources. Findings: Ninety-seven patients (97/277, 35% response rate) completed the survey. Most were women(67%, n=65/97), Caucasian(93%, n=90/97) and received outpatient care during acute COVID-19 illness (79%). Fifty percent reported wait time of 1-3 months and 40% traveled >1 hour for the appointment at PASC clinic. The most common symptoms >3 months from initial infection were fatigue (77%), brain fog (73%), exercise intolerance (73%), anxiety (63%), sleep difficulties (56%) and depression (44%). A minority of patients reported significantly reduced functioning ([≥]1.5 SD below mean) of their physical health (22.5%), mental health (15.9%) and cognitive abilities (17.6%). Qualitative analysis of open-ended answers added valuable context to quantitative results. Satisfaction with clinical services was high though participants identified barriers to care including scheduling delays and financial concerns. Respondents suggested potential strategies for optimizing recovery including continuity of care, a co-located multispecialty clinic and being provided with timely information from emerging research. Conclusion: Our study reports high PASC symptom burden, its impact on health and patient experience with healthcare. It is important that primary healthcare professionals listen to patients with empathy and support them during recovery. Healthcare systems and policymakers should focus on accessible, comprehensive, and patient-centered integrated care.

Post-acute sequelae of SARS-CoV-2 (PASC) is a complex condition with multisystem involvement. [1] [2] [3] [4] [5] [6] In a longitudinal study 87.4% patients who recovered from COVID-19 had at least one symptom at 60 days of follow-up. 7 At 9 months' follow-up, studies report the presence of one or more symptoms in 30-36% of survey respondents. 8, 9 A recent report of 342 patients, showed that 40.7% had at least one symptom at one year of follow-up. 10 The persistence of symptoms can significantly affect patients' quality of life. 2, 7, 11, 12 Rural areas were disproportionately affected by SARS CoV-2 infection and people living in underserved communities face unique barriers to optimal care. [13] [14] [15] [16] [17] Currently in Iowa, more than 500,000 cases and 7200 deaths have been reported with major outbreaks affecting the diverse work force in meat packaging plants in Iowa, United States (US). 18, 19 Mortality rate in some rural counties in Iowa (290 deaths per 100,000) has surpassed the national US mortality rate This study received Institutional Review Board approval (#202105502). Patients who attended PASC clinic at UIHC through the in first year after clinic inception (June 12 th 2020), were invited to complete an online mixed-methods survey. By completing the survey, patients provided consent to participate. Patients were emailed information about the study and a link to the survey, with two weekly reminders sent to non-respondents.

The survey (Appendix 1) was drafted using Qualtrics (Qualtrics, Provo, UT). We collected demographic data (age, sex, and ethnicity) and asked about the 1) timing of initial SARS-CoV-2 infection, highest level of care utilized, symptoms at the time of initial infection, symptoms three months post-infection and up to four most concerning symptoms at the time of the survey; 2) All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint impact of symptoms on perceived physical and mental health, assessed by the Patient Reported Outcomes Measurement Information System Global Health-10 item questionnaire (PROMIS GH-10) and effect on cognitive ability assessed by the PROMIS Cognitive Function-Abilities 4a-4 item questionnaire (PROMIS CA-4a); 26-28 and 3) experiences with the PASC clinic including wait time for first appointment, distance traveled, satisfaction with services (scheduling, testing, imaging, staff), subspecialty referrals provided and completed, barriers to attending subspeciality referrals, and recommended resources for other patients with PASC. Participants also answered open-ended questions, identifying any other resources that would be helpful in an "ideal post-COVID clinic" and adding any other comments.

Non-responder analysis was run to compare demographics and key clinical characteristics between survey responders and non-responders using chi-square tests of independence and independent sample t-tests as appropriate. Differences were expressed in terms of mean differences or odds ratios with 95% confidence intervals (CI).

Symptoms during initial infection and at three months post-infection were compared within respondents using a sign test to determine the shift in a respondent's symptoms over time;

"positive shift" indicated the number of symptoms increased over time, a "negative shift" indicated symptoms decreased, and a "tie" indicated that the number of symptoms stayed the same. Internal consistency and reliability of the two PROMIS instruments in this sample was established using a Cronbach's alpha with α = 0.60 being sufficient and α ≥ 0.80 being ideal.

Once confirmed, raw scores for the physical and mental health components of the PROMIS GH-10 and the PROMIS CA-4a were transformed into normatively referenced t-scores with a mean 7 of 50 and SD of 10 per scoring guides. 28, 29 These scores were classified as either "normal" (or within normal limits) defined as mean ±1.49 SDs or as "significantly reduced" at ≥ 

The survey response rate was 35% (97/277). Most respondents were women (67%), Caucasian (92.8%) and were diagnosed with SARS-CoV-2 between March 2020 and April 2021. Non-Caucasian patients were over three times more likely to be non-responders compared to Caucasian patients, with an odds ratio (OR) of 3.06 (95% CI = 1.23-7.64, p = 0.013).

All respondents were at least 64 days from their initial positive test when they completed the survey, with a median interval of 234 days (IQR = 124 were similarly likely to receive care in an outpatient or home setting, (p = 0.45). Women were less likely to be admitted to the hospital or ICU (22%) than men (28%), which was not statistically significant (p = 0.47).

Symptoms were classified into six broad body systems: general, neurological/nerves/memory, lung, heart, gastrointestinal, and mental health (Appendix 1). At the time of diagnosis, the most common symptoms reported were fatigue (88%), shortness of breath (73%), exercise intolerance (73%) and palpitations or heart racing (73%). The most common reported symptoms three months post-infection included fatigue (77%), "brain fog" or memory or cognitive impairment (73%), exercise intolerance (73%) and shortness of breath (70%; Figure 1 ).

Respondents were asked to report most concerning symptoms that they were experiencing at the time of survey (Table 2 ). Fatigue (52%), "brain fog" (39%), and shortness of breath (30%) were the most cited ongoing concerns, followed by cough (22%). Women generally reported a higher prevalence of all symptoms compared to men (as shown in Table 2 ), particularly fatigue (15 percentage points more) and cough (26.2 percentage points more), but far fewer men than women provided answers to this open-ended question.

The median number of general symptoms reported was 3.0 for both the initial infection and three-month post-infection periods; however, 42.3% of participants reported fewer symptoms at three months compared to baseline, 20.6% reported more symptoms, and 37.1% reported the same number of symptoms (p = 0.01; Table 3 ). Only 15.5% of patients reported decreased symptoms at three months compared to 29.9% reporting increased symptoms (p = 0.05).

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint

The total Cronbach's alpha coefficients for the PROMIS GH-10 and PROMIS CA-4a were α = 0.78 and α = 0.96, respectively; thus, both instruments were considered acceptably reliable for our sample. The distribution of scores for PROMIS GH-10 and PROMIS CA-4a are shown in Table 4 . The odds of expressing reduced physical health, mental health, and cognitive function did not differ by sex or initial care (outpatient vs. inpatient; Appendix 2). In contrast, we found significant differences between patients expressing normal (mean ±1.49 SD) versus significantly reduced (≥1.5 SD) physical health, mental health, and cognitive abilities across five of six body systems as well as median total symptom burden at three months post-infection (Table 5 ). Those showing reduced mental health reported double the average neurological symptoms (6, IQR = 2) compared to those who did not report reduced mental health (3, IQR = 2.25, p < 0.001).

Similarly, the total number of symptoms reported by those with reduced mental health was 7.5 greater (median = 18.5, IQR = 5.25) than participants without (median = 11, IQR = 6.5, p < 0.001).

Fifty percent of patients reported waiting 1-3 months, whereas 37% were seen within one month of contacting the clinic for a first appointment. Only 8 patients reported waiting 3-4 months for their first appointment. Most (60%) patients traveled less than one hour for their clinic appointment.

Over 50% of our participants reported receiving one to three different specialty referrals after COVID-19 diagnosis, most commonly to pulmonology (50%), cardiology (27%), pulmonary All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint rehabilitation (20%) and physical & occupational therapy (18%). (Figure 2 ) As symptom burden increased, the number of referrals to various subspecialists increased. There were moderate, positive correlations between total initial symptoms and referrals made (r = 0.45, p < 0.001) and total initial symptoms and referrals completed (r = 0.44, p = < 0.001).

On direct survey questions, the most common barriers reported for completing referrals were delays in getting appointments or not getting an appointment (21%) and financial concerns with uncertainty about insurance coverage for tests and appointments (16%). Other barriers reported included multiple clinic visits with different providers adding complexity of care (9%), travelling a long distance for the appointments (8%), inability to miss work to attend appointments (3%), limitations from symptom burden (3%), and preference for a virtual appointment rather than inperson due COVID-19 infection with in-person care (3%). Other barriers (18%) included responses such as "waiting to see if symptoms get better", "not sure which specialty to see", and "no referrals were made", and "insurance will not cover tests/physical therapy".

Most participants (between 61% and 93.2%) indicated they were either "satisfied" or "very satisfied" with their experiences and the dissatisfaction rate with all the services was less than 20%. (Table 6 )

Participants were asked to rate how helpful potential candidate resources and services might be in addressing PASC (Table 7) . "Very helpful" or extremely helpful options included: 1) continuity of care i.e., a regular follow-up appointment scheduled with the same doctor (75%), 2) providing a multi-specialty clinic i.e., different doctors located in the same clinic space (70.4%), All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint and 3) additional patient education from reliable sources (68.7%). Conversely, 30% or more found providing access to social workers, access to a scheduling coordinator, and group therapy interventions to be either "slightly helpful" or "not helpful at all."

Overall, 51% of participants responded to the two open ended questions with answers ranging from 3 to 230 words. We categorized comments into the following broad themes: clinic experience, patient health, and "wish list." Clinic experience. Participants addressed their experiences in the PASC clinic and post COVID-19 care received elsewhere. Participants identified scheduling as one area for improvement.

However, participants described appreciating when they received quick responses to worries ("I had an incident… and they got me in … right away"). Other concerns included distance to the PASC clinic, and the costs of testing and treatment, especially if not covered by insurance.

communication. Some participants perceived that some clinicians valued test results more than patients' perceptions of their health ("tired of feeling cast off by doctors as just anxiety").

Participants advised clinicians to listen to their patients, specifically about their symptoms in relation to recommendations for exercise which patients felt were beyond their capabilities. In contrast, participants appreciated when they felt clinicians listened ("I have never felt so heard and understood," "I was extremely pleased to feel validated with my health and symptoms," "did not treat me like I was just making stuff up"). Participants understood that knowledge about COVID-19 was evolving, and clinicians were learning along with patients. However, they valued the opportunity to receive treatment and recommendations, including inhalers, pulmonary and physical therapy, and exercise regimens ("I felt like your clinic actually had an idea after testing All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. They suggested that speedy initial and follow-up appointments, timely referrals, and consistent follow-up and coordination would improve patient experience and allay frustration with ongoing symptoms. They described valuing continuity of care and wanting their providers to share information. They also sought access to new types of care and specialties, for example, through a multidisciplinary clinic or referrals to a wider range of providers. Overlapping with this interest in specialty care, participants requested additional tests and treatments. Requested avenues for exploration included COVID-19 impact on hormones, and additional cardiac or pulmonary All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint testing, including during exertion. Requested treatments included cognitive and behavioral rehabilitation or therapy, and cardiac rehabilitation. Additional suggestions included support groups for patients and bilingual services.

Research represented a subtheme of interest in this category. Participants wanted to know that clinicians were well-educated on disorders (e.g., dysautonomia) and up to date on current research (e.g., on hormonal disruption) and experimental therapies. One participant suggested clinicians seek information across research and clinical centers about "what's worked for them, and things being tried." In addition, responses indicate that patients are interested in participating in research and want to hear updates from their clinicians ("I wish someone would keep us updated with new advancements,", "I hope we will be notified as treatments become a thing for people with lasting symptoms").

Our mixed-method survey study highlighted experiences of patients with PASC, the impact of symptoms on their health and their experience with healthcare. The timely feedback by patients for a newly developed PASC clinic in the first year helped us understand barriers and identify key areas of improvement. In our PASC clinic, patients were offered particularly detailed assessment including pulmonary evaluation and behavioral health screening at a single visit.

To date various studies have reported multiple symptoms in PASC. 7-10 Within our study's assessment of most concerning PASC symptoms, patients reported fatigue (52%), "brain fog" (39%), and shortness of breath (30%). Our study is in line with previous studies that have reported negative impact on quality of life in COVID-19 survivors. 7, 8 On PROMIS measures, patients reported significantly reduced functioning (≥1.5 SD below mean) in their physical health (22.5%), mental health (16%) and cognitive abilities (18%). Interestingly, symptoms during All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint acute illness did not relate to reduced scores, but patients who reported multiple symptoms at three months scored low in physical, mental, and cognitive PROMIS measures. Therefore, we were also referred to a psychologist. Adopting established practices like incorporating simple distress thermometers can also be used to empower clinicians to provide psychosocial support for patients. 37

The qualitative analysis of patient comments adds nuance and context to some of the quantitative results and highlights the profound impact of symptoms on patients' everyday lives. Our study echoes result from other studies where patient with PASC preferred continuity of care, multidisciplinary rehabilitation, and attentive listening. 6, 38, 39 Therefore, we advocate for adequate appointment time for detailed assessment and counselling. 40 Multiple co-located specialties in a same clinic may not be possible given multisystemic symptoms which may need several different providers for several concerns in one day. However, in our PASC clinic we All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint established several partnerships with different specialties including behavioral health, neuropsychology (follow up for cognitive assessment) and pulmonology (follow up for chronic lung disease) with identified clinical 'champions' who provided subspeciality assessment in a timely manner.

Our experience brings to attention the unique challenges and needs of patients in rural areas with long wait times for appointments, long distances travelled for health care assessment and financial concerns with limited access to healthcare. Further referral to different specialties adds to care complexity along with cost and time lost from work and additional travel. 14, 16 Nevertheless, the appointment wait times and distance travelled reported in this study should be contextualized; our large academic center provides resources for patients across the state and operates the only PASC clinic in the area. Partnering with community leaders at outreach clinics (e.g., established UIHC outreach clinic at locations across the state) and local resources (e.g., physical rehabilitation centers) could strengthen the referral system. We also provided follow up care with telemedicine for established patients. In addition, a dedicated clinical nurse coordinator was appointed to assist and coordinate care, especially scheduling tests, subspeciality referrals and follow up care. Furthermore, adequate steps should be taken by policymakers and stakeholders to alleviate the additional economic burden related to evaluation and management of PASC. 41, 42 Several limitations of our study warrant consideration. The sample was primarily women, Caucasian, and symptomatic; therefore, the findings are less generalizable to men, different racial/ethnic groups, and asymptomatic patients. We were not able to send the survey in other languages like Spanish which may have decreased survey responses from the Spanish-speaking population. Other races were significantly unrepresented in our survey; however, it is also All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Our study reports high PASC symptom burden, its impact on health and patient experience with healthcare. It is important that primary care professionals listen to patients with PASC with empathy and support them during recovery. Healthcare systems and policymakers should focus on accessible, comprehensive, and patient-centered integrated care.

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; Table 1 . Demographic comparisons between responders and non-responders. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. *Participants could enter up to four different symptoms, so total percent exceeds 100%; percentages were calculated out of the total number of participants who responded to these questions.

All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. T  a  b  l  e  7  .   P  e  r  c  e  i  v  e  d  h  e  l  p  f  u  l  n  e  s  s  o  f  f  u  t  u  r  e  r  e  s  o  u  r  c  e  s  .   H  o  w  h  e  l  p  f  u  l  d  o  y  o  u  t  h  i  n  k  e  a  c  h  o  f  t  h  e  f  o  l  l  o  w  i  n  g  r  e  s  o  u  r  c  e  s  c  o  u  l  d  b  e  t  o  y  o  u  o  r  o  t  h  e  r  p  a  t  i  e  n  t  s  w  i  t  h  p  o  s  t  -C  O  V  I  D  s  y  m  p  t  o  m All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.20.21266640 doi: medRxiv preprint

More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Res Sq

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge

The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis

Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services

Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in

Evolution of COVID-19 symptoms during the first 12 months after illness onset

Quality of Life (QoL) Is Reduced in Those with Severe COVID-19 Disease, Post-Acute Sequelae of COVID-19, and Hospitalization in United States Adults from Northern Colorado

Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients

Unequal Distribution of COVID-19 Risk Among Rural Residents by Race and Ethnicity

Rural and Urban Differences in COVID-19 Prevention Behaviors

Exposing some important barriers to health care access in the rural USA. Public Health

Spatial Disparities in Coronavirus Incidence and Mortality in the United States: An Ecological Analysis as of

All rights reserved. No reuse allowed without permission

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity